Member Info for Bennster

Reaper/Scot and all - from one who is a regular reader, not a regular poster on this share, I appreciate hearing both sides while it's civil and discusses detail.
Helps me to form a picture beyond the snippets of RNS/Investment gossip. I have never filtered anyone ever on any board because I'd never want to cut out an angle, but respect others decision to do so.
So thank you for your contributions either way.

More permission is being sought and will be given for TB to issue himself more shares this year.
Up to 20 Million if he wants them. You can work out who that will suit
Draw your own conclusions, but definitely no mention of year end performance.

All true Armagedon.
I would also add that if the test worked, was approved, certified and did what it says on the tin (basically was a world beater) then why would prospective buyers all turn away from it as they have done?
We know the reality - it's been a yellow brick road for 12 months whilst TB flogged his shares, then placed again.
In the mean time I'm frustrated that COVID testing is STILL the only topic of conversation on a message board that should be focussing on the whole of BRH's investment portfolio, not one part which has already been put in the bottom drawer by the company itself.

Hi Yozzer73.
Fear not! I spoke to Viv yesterday - he told me BRH are going "to the moooon!". Why would he tell me that if it wasn't true?
I also tweeted Prof Carl to double check and he said "COVID is the most important event in world history. We're the only people who can save the Earth with the CX3000 super test. I'm going to run for POTUS".
Guy on Reddit says the new target price is £80 a share now TB has bought some. Why would he say that if it wasn't true eh?

Hurrah!

Of course he does. Seeing as he's on the inside it's hard for him not to.
It's a bit like wondering why you lose at poker when the other guys all have a spare deck under the table.....

With you there! Extreme discount is the right way to put it.
I'm a rubbish day trader - for me it's all tucked away in the ISA because I believe in a long term result, which will set me up.
I'm not a fan of unexpected twists and volatility because I keep tabs every day on my investments, so this is why I am unimpressed with another placing!

I beg to differ with your angleto a degree.
You and I, like most LTH's here believe that the true value is much higher than the 5p we see now. We do the maths, see the income streams and believe we should be lots higher.
BUT
What price shares are sold for today is a function of what they were bought for - and because there is a massive chunk of LVCG share capital issued at 3.5p or 5p in the last 6 months, the price people will sell at can be anything above 5p to be profitable.
Just because it's idealistic for us to hold for a price we deem correct, we have to understand that once there's a big profit to be realised and risk remains out there in the big wide world, then temptation (or prudence) rules and shares have to be churned.
This is why I am certain we'll see a corridor of value for a long time between 5p and 6p - totally independent of true value.
If you don't like this please don't shoot the messenger - this is the inevitable consequence of such dilution and repeated placings. The good news is that over time we will see shares in the hands of people who need to see an increasingly high price to get their profit so things should gradually get better. It just means this won't skyrocket - it'll be a slow burner over the next 24 months.

Nope - try more reading practice.

I first asked you to explain the 80p price you quote for the release of a test that the company itself admit probably won't be sold....

There are times when it's best to stop making yourself look silly Starknight

If there was an option to sell this thing they wouldn't have released the RNS - there's no mention in that RNS that the sale was UK restricted, just that the UK approach was cooling interest.
Today France has relaxed it's COVID rules too.
In the mean time there are a myriad of other tests out there - why is Paraytec the life saver worldwide??
In the mean time - instead of protesting so loudly how about to explain to all of us where this 80p comes from and why even higher with Sepsis test?

Hah!!
Sadly finals will probably be out in June, so any divi will be later still.

Correct Mrninjazx6.
They did say they would actively consider a dividend after trebling the balance sheet value of Phasefocus due to its activity.

Starknight - please see below from Official RNS:

The UK Government's decision to rapidly wind down the testing and isolation requirements for UK citizens and travellers to the UK has abruptly changed the nature of the COVID-19 test market which has led to a slowing of discussions with the remaining potential acquirers of Paraytec Limited and its COVID-19 test. It now appears unlikely that Braveheart will be able to conclude a sale with one of the remaining engaged parties at an acceptable price in the foreseeable future.

Now compare and contrast with your last post:

The SP should correct and hopefully rebound back into the 80p area if the Covid-19 Rapid Test CX300 is officially launched and even highr if the Sepsis Test is launched.

It's only a guess, but I reckon year end results (end of March) include a dividend - Phasefocus led.
The share price has spent too long overvalued and ramped on COVID, now it's the other way around.
18p is a floor for the last placing so buying at 11.5p makes sense for TB if he knows what's coming - and of course he does!

No Castle.
We already know Paraytec will probably not be sold at an acceptable price.
The year end results will be impacted by the relative success of Phasefocus - that's the driver here.

I understand the need for short term cash. What I don't like is getting it by placing shares yet again....
With interest rates as they are a short term loan would be better business sense.
To rectify this - as somebody said earlier - DC needs to buyback after May, but may have to do so at a price more expensive than a simple loan.

In truth Knigel I reckon it'll be a bit of both - newsflow between now and May will cause rises in SP.
The outright 10% ers will use this to get their reward - but then again if you've wrapped a lot into a placing why not de-risk if you can turn 40% profit at 7p?
For those of us who did the maths back before the last 2 placings we now have a lower SP target because there's more shares in issue. I still believe it should ultimately be north of 10p after May, but this kind of share issuance and turnover causes "fog" in sentiment and clouds the real value.

sorry - typo - should say 6p is the ceiling for a while...

5p is the floor - said this many times before.
Sadly 5p will also be a ceiling for a while....
I'm not excited by 0.3p here or there - I want to see this moving north of 6p and that will take much more time.
I expect some weeks of trading in a narrow +/- 1p channel.

That's exactly my fear.
I dividend would be diluted now - and any retained profit will get frittered away.
DC needs to bring this business model to maturity now - use only retained earnings to pay the bills and grow organically in the many areas we're already invested in, like KPOP....

This is the wording from today's RNS and it matches previous placings.

The Company has entered into a placing agreement dated 11 March 2022 (the "Placing Agreement") with Monecor pursuant to which they, as agents for the Company, have procured placees for the Placing Shares at the Placing Price.

I believe that's more PI's